共 69 条
- [1] Kamlet, A Framework for Cost-Utility Analysis of Government Health Care Programs: The Comparative Benefits Modeling Project, (1992)
- [2] Steiner, Public expenditure budgeting, The Economics of Public Financing. Studies of Government and Finance, pp. 241-360, (1974)
- [3] Elixhauser, Luce, Cost-benefit and cost-effectiveness analysis from 1979 to 1990: A bibliography, Med Care, 31, pp. S1-S11, (1993)
- [4] Drummond, Current concerns about economic evaluation, Pharm Times, 10, pp. 18-19, (1990)
- [5] Drummond, Brandt, Luce, Rovira, Standardizing economic evaluation methodologies in health care, Int J Technol Assess Health Care, 9, pp. 26-36, (1993)
- [6] Hillman, Eisenberg, Pauly, Et al., Sounding board: Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies, NEJM, 324, pp. 1362-1365, (1991)
- [7] Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: Including submissions involving economic analysis, (1990)
- [8] Henry, Economic analysis as an aid to subsidization decisions: The development of Australian guidelines for pharmaceuticals, PharmacoEconomics, 1, pp. 54-67, (1992)
- [9] Canadian Coordinating Office for Health Technology Assessment, Guidelines for Economic Evaluation of Pharmaceuticals: Canada, (1994)
- [10] Memorandum: “Status Report on Ontario's Draft Guidelines for Economic Analysis of Drugs”